Reduced antibiotic prescribing for acute respiratory infections in adults and children
- PMID: 19843412
- PMCID: PMC2751936
- DOI: 10.3399/bjgp09X472610
Reduced antibiotic prescribing for acute respiratory infections in adults and children
Abstract
Background: Recent public health efforts, including in the UK and US, have targeted decreasing unnecessary antibiotic use. In the US, prescribing for acute non-specific respiratory infections (ARIs) has decreased, but broad-spectrum antibacterial prescribing has soared.
Aim: To assess recent trends in antibacterial prescribing for ARIs in the UK.
Design of study: Retrospective cohort.
Setting: The Health Improvement Network database.
Method: Outpatient ARI visits from 1 January 1990 to 31 December 2004 were selected. Outcomes were antibacterial and broad-spectrum antibacterial prescriptions per thousand person-years, and the probability of receiving an antibacterial and broad-spectrum prescription conditional on an ARI visit.
Results: From 1990 to 2004, antibacterial prescribing rates for ARIs decreased from 55.0 to 30.3 prescriptions/1000 person-years for adults and from 124.8 to 46.3 prescriptions/1000 person-years for children (P=0.001). The probability of receiving an antibacterial prescription after an ARI visit decreased from 70.8% to 59.5% for adults and from 46.1% to 30.8% for children (P=0.003 and 0.007, respectively). Antibacterial prescribing declined faster for younger than for older adults. Broad-spectrum antibacterial prescribing rates decreased from 3.8 to 2.9 prescriptions/1000 person-years for adults and from 5.2 to 2.2 prescriptions/1000 person years for children (P=0.005 and 0.003, respectively). The probability of broad-spectrum prescribing did not demonstrate a significant linear trend for adults (P=0.16), and decreased for children (P=0.01).
Conclusion: UK antibacterial prescribing for ARIs has declined, similar to US trends, but there was no concomitant increase in low broad-spectrum prescribing. The success of UK strategies for limiting antimicrobial use has implications for programmes in other countries.
Figures
Comment in
-
Respiratory infections.Br J Gen Pract. 2009 Dec;59(569):945. doi: 10.3399/bjgp09X473222. Br J Gen Pract. 2009. PMID: 20875264 Free PMC article. No abstract available.
References
-
- Lonks JR, Garau J, Gomez L, et al. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis. 2002;35(5):556–564. - PubMed
-
- Interagency Task Force on Antimicrobial Resistance. A public health action plan to combat antimicrobial resistance. Part 1: domestic issues. Atlanta: Interagency Task Force on Antimicrobial Resistance; 1999. http://www.cdc.gov/drugresistance/actionplan/index.htm (accessed 23 Mar 2009)
-
- Austrian R. Confronting drug-resistant pneumococci. Ann Intern Med. 1994;121(10):807–809. - PubMed
-
- Metlay JP, Hofmann J, Cetron MS, et al. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin Infect Dis. 2000;30(3):520–528. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials